Navigation Links
Cell Therapeutics, Inc. (CTI) Appoints Former Managing Director, Head of West Coast Biotechnology for Oppenheimer/CIBC Matthew J. Plunkett Executive Vice President, Corporate Development
Date:9/3/2012

SEATTLE, Sept. 4, 2012 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC), a company focused on translating science into novel cancer therapies, today appointed former  Managing Director and Head of West Coast Biotechnology for Oppenheimer & Co. and its U.S. predecessor, CIBC World Markets, Matthew J. Plunkett, Ph.D., as CTI's Executive Vice President, Corporate Development. Dr. Plunkett will lead CTI's partnering strategy including development collaborations, licensing agreements, and strategic alliances.

Dr. Plunkett has more than 15 years' experience in the biopharmaceutical industry. This includes 9 years at Oppenheimer & Co. and CIBC World Markets.  Dr. Plunkett advised on more than 70 completed transactions companies in the U.S., Europe and Australia, including more than $4 billion in equity and equity-linked transactions and $1 billion in merger, acquisition and other financial advisory transactions.

Most recently, Dr. Plunkett was Chief Financial Officer at the California Institute for Regenerative Medicine, a $3 billion fund for California stem cell research. He also served as Vice President and Chief Financial Officer at iPierian, a privately-held development-stage biotechnology company. He began his scientific career at Sunesis Pharmaceuticals and Axys Advanced Technologies. Dr. Plunkett received a doctorate in Organic Chemistry from the University of California, Berkeley, and a bachelor of science in Chemistry from Harvey Mudd College, Claremont, California.

"Matt has a wealth of experience in financing, mergers, acquisitions and technology/market assessments," said James A. Bianco, M.D., President & CEO of CTI.

"CTI is one of a select few companies that both have the opportunity of a product approved in Europe, and drug candidates with attractive commercial potential for different blood-related cancers," Dr. Plunkett said. "It is all the more impressive that CTI has been able to e
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
2. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
3. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
4. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
5. Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer
6. Nephros Appoints John C. Houghton as President and Chief Executive Officer
7. Elsevier Appoints New President of Elsevier CPM Resource Center
8. GenWay Biotech Appoints New Vice President of Custom/OEM
9. Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales
10. Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
11. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 25, 2015 Research and ... "Veterinary / Animal Vaccines Market by Product, Diseases ... to their offering. The global animal vaccines ... from $5,507.3 Million in 2015, at a CAGR of ... fueling market growth are growing prevalence of animal diseases, ...
(Date:7/2/2015)... , July 2, 2015 Legal-Bay LLC, ... District Judge Joseph Goodwin in the Southern ... consolidated 26 transvaginal mesh cases against Ethicon for a ... . The cases for the 26 women include claims ... a device made my Johnson & Johnson,s Ethicon subsidiary. ...
(Date:7/2/2015)... , July 2, 2015 ... to improving access to HIV treatments   ... strategic manufacturing agreement to enable production in China ... source of the dolutegravir active pharmaceutical ingredient (API), and will ... finished product (dolutegravir 50mg, marketed under the name Tivicay®) for ...
Breaking Medicine Technology:Veterinary / Animal Vaccines Market 2015 - Global Forecast to 2020 for the $7.19 Billion Industry 2Judge Sets Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 2Judge Sets Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 3ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 2ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 3ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 4ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 5ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 6
... indicate statistically significant improvement in ACR20 responses over ... MEDX ) today announced that the ... active rheumatoid arthritis (RA) receiving methotrexate successfully met ... recently completed 70-patient multi-center, randomized, double-blind, placebo-controlled Phase ...
... DIEGO, May 14 Cadence Pharmaceuticals, Inc. ... has submitted a New Drug Application (NDA) to the ... product candidate, Acetavance(TM) (intravenous acetaminophen), for the treatment of ... approved, Acetavance would become the first new intravenous analgesic ...
Cached Medicine Technology:Medarex Announces Primary Endpoint Achieved in MDX-1100 Anti-IP-10 Antibody Phase 2 Trial for Rheumatoid Arthritis 2Medarex Announces Primary Endpoint Achieved in MDX-1100 Anti-IP-10 Antibody Phase 2 Trial for Rheumatoid Arthritis 3Medarex Announces Primary Endpoint Achieved in MDX-1100 Anti-IP-10 Antibody Phase 2 Trial for Rheumatoid Arthritis 4Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever 2Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever 3Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever 4Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever 5
(Date:7/2/2015)... ... ... Many Fourth of July celebrations will include fireworks this summer, so it’s ... some tips to promote the proper use of fireworks. , According to the U.S. ... with fireworks-related injuries in the month surrounding the Fourth of July. Amica is sharing ...
(Date:7/2/2015)... , ... July 02, 2015 , ... As Americans celebrate ... the hot temps, skin cancer is on the rise. July is UV Safety Month, ... raising awareness about the importance of getting skin checks. Experts say most skin cancers ...
(Date:7/2/2015)... ... ... The ZAC Foundation, a national leader in water safety education and drowning ... stay water safe with the help of a young polar bear named Zeke. ... follows Zeke’s water safety journey. Zeke, who is afraid of the water and ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... R. Krishnareddy, M.D., to the orthopedic and spine surgery team at their Anaheim ... strains, bursitis, and tendonitis. Along with the spine and spine surgery, Dr. Krishnareddy ...
(Date:7/2/2015)... York, NY (PRWEB) , ... July 02, 2015 ... ... City for Carpal Tunnel treatment and wrist pain treatment. Dr. Lev Kalika, founder ... NYDNRehab – and a leading international authority on the conservative treatment of back, ...
Breaking Medicine News(10 mins):Health News:6 Fireworks Safety Tips from Amica Insurance 2Health News:Local Physicians Warn of Holiday Health Hazards 2Health News:Local Physicians Warn of Holiday Health Hazards 3Health News:Local Physicians Warn of Holiday Health Hazards 4Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 2Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 3Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 2Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 2Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 4
... FRANCISCO, Sept. 3 Blue Shield of California announced today that ... health services for Blue Shield members impacted by the fires in ... difficult time, we want to make it as easy as possible ... access to the medical services they need," said Meredith Mathews, M.D., ...
... , , NEW YORK, Sept. 3 ... Month by enhancing the support services already available to its group life ... affected by the loss of a loved one - The Healing ... (written by Ellen Sabin and published by Watering Can Press). , ...
... , , , OKLAHOMA ... located in Oklahoma City, today announced that it has partnered ... providers of specialty surgical services. Surgical Hospital of Oklahoma is ... inpatient acute care in a number of specialties including pain ...
... higher than with seasonal flu , THURSDAY, Sept. 2 ... complications from the H1N1 swine flu since the virus ... younger than 18, a new government report shows. , ... at least one chronic high-risk "neurodevelopmental condition," such as ...
... Positive interaction beats punishment when trying to reach a goal, ... Trying to determine the best way to get people to ... Economics have found that a carrot is better than a ... with each other to solve a group social dilemma, our ...
... , NEW YORK, Sept. 3 Reportlinker.com announces that a ... Cosmetic Surgery Markets: Products and Services ... REPORT HIGHLIGHTS , , , ... billion in 2008, a figure that is expected to reach $40.1 billion ...
Cached Medicine News:Health News:Blue Shield of California Streamlines Access to Benefits and Prescriptions for Wildfire Victims 2Health News:Anthem Life & Disability Insurance Company offers The Healing Book to Help Young Life Insurance Beneficiaries Cope with the Loss of a Loved One 2Health News:Surgical Hospital of Oklahoma to Partner with Surgical Care Affiliates 2Health News:Swine Flu Poses Risk to Kids With Neurological Conditions 2Health News:Swine Flu Poses Risk to Kids With Neurological Conditions 3Health News:Swine Flu Poses Risk to Kids With Neurological Conditions 4Health News:Rewards Are Key to Cooperation 2Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 2Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 3Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 4Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 5Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 6Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 7Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 8Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 9Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 10Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 11Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 12Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 13Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 14Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 15Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 16Health News:Reportlinker Adds Cosmetic Surgery Markets: Products and Services Report 17
For the quantitative in vitro determination of IgE in Human Serum or Plasma....
For the quantitative in vitro determination of IgG in serum and plasma. This product is suitable for use on the Aeroset...
Latex-enhanced immunoturbidimetric assay for the quantitative in vitro determination of C-reactive protein in serum and plasma...
Latex agglutination slide test for the qualitative and semi-quantitative in vitro determination of CRP in serum....
Medicine Products: